FDA Clearance Tracker · DEN150058
Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek II, Level 1 and Amplichek II, Level 1 MiniPak, Amplichek II, Level 2 and Amplichek II, Level 2 MiniPak, Amplichek II, Level 3 and Amplichek II, Level 3 MiniPak
Last checked: Nov 20, 2026Latest source record: Mar 28, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2016
De Novo granted
Time to decision
103 days
Received Dec 16, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Post-NSE
Device class
Class II
The decision
- FDA number
- DEN150058
- Device name
- Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek II, Level 1 and Amplichek II, Level 1 MiniPak, Amplichek II, Level 2 and Amplichek II, Level 2 MiniPak, Amplichek II, Level 3 and Amplichek II, Level 3 MiniPak
- Applicant
- Bio-Rad Laboratories
- Applicant location
- Irvine, CA
- Received
- Dec 16, 2015
- Decided
- Mar 28, 2016
- Decision
- De Novo granted
- Submission type
- Post-NSE
Device type
- Device type
- Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN)
- Device class
- Class II
- Regulation
- 21 CFR 866.3920
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN150058
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Bio-Rad Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BioPlex 2200 Lyme Total510(k)
K183446 · Decided Mar 12, 2019 · 90 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K181661 · Decided Feb 13, 2019 · 233 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
K180577 · Decided Jun 22, 2018 · 109 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.